Teleflex (TFX) announced that its Board of Directors has authorized a share repurchase program for up to $1 billion of the company’s common stock. The program will primarily be funded with proceeds from the sale transactions. “The sale transactions and this authorization are a testament to the Board’s confidence in our ability to advance our strategic objectives and drive growth across our remaining businesses,” said Mr. Kelly. “We have a longstanding commitment to return capital to shareholders and will continue to review our capital allocation strategy with a focus on maximizing long-term value creation.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TFX:
- Teleflex’s Strategic Sale and Uncertain Valuation Lead to Sell Rating
- Optimistic Buy Rating for Teleflex Driven by Strong Vascular Business Growth and Strategic Innovations
- Teleflex price target lowered to $120 from $135 at RBC Capital
- Teleflex Reports Strong Revenue Growth Amid Challenges
- Teleflex’s Earnings Call: Growth Amid Challenges